Retinalgenix Technologies INC 10-K annual reports
Annual reports — audited financials, the full risk-factor list, and management’s account of the year.
OID
RetinalGenix Technologies Inc. outlines its strategy to prevent vision loss through innovative devices and drug development while acknowledging substantial financial challenges and a going concern uncertainty.
OID
RetinalGenix Technologies Inc. has filed its annual 10-K report, detailing its progress in developing medical devices and therapeutic candidates for ophthalmic and systemic diseases, while also highlighting its financial position and future capital needs.